Bausch Health Companies Inc.
Bausch Health Companies Inc. (BHC.TO) Revenue
Annual & quarterly revenue history · segment & region breakdown
BHC.TO · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsBausch Health Companies Inc. trailing twelve-month (TTM) revenue is $8.76B, an increase of 8.53% year-over-year from $10.45B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $10.45B | +$0.82B | +8.53% |
| 2024-12-31 | $9.63B | +$0.87B | +9.91% |
| 2023-12-31 | $8.76B | +$0.63B | +7.79% |
| 2022-12-31 | $8.12B | -$0.31B | -3.68% |
| 2021-12-31 | $8.43B | +$0.41B | +5.07% |
| 2020-12-31 | $8.03B | -$0.57B | -6.67% |
| 2019-12-31 | $8.60B | +$0.22B | +2.64% |
| 2018-12-31 | $8.38B | -$0.34B | -3.94% |
| 2017-12-31 | $8.72B | -$0.95B | -9.82% |
| 2016-12-31 | $9.67B | -$0.82B | -7.86% |
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare BHC.TO revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Bausch Health Companies Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Bausch Health Companies Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Bausch Health Companies Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BHC.TO revenue · 4 questionsBHC.TO's trailing twelve-month (TTM) revenue is $8.76B. That is an increase of 8.53% year-over-year from $10.45B in FY2025.
▸ Source: FMP · Bausch Health Companies Inc. SEC filings · GAAP · Bausch Health Companies Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026